These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2945381)

  • 21. [Effects of clofibrate, silybin, safflower oil and lamindran on liver peroxisome proliferation and enzyme activities in rats].
    Wu SG; Shen YA; Zheng Z; Long K
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):283-4. PubMed ID: 2954381
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular effects of the alpha2-adrenergic receptor agonist medetomidine in clinically normal cats anesthetized with isoflurane.
    Golden AL; Bright JM; Daniel GB; Fefee D; Schmidt D; Harvey RC
    Am J Vet Res; 1998 Apr; 59(4):509-13. PubMed ID: 9563639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats.
    Hof RP; Hof A
    J Cardiovasc Pharmacol; 1984; 6(1):68-75. PubMed ID: 6199614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of saffan on cardiopulmonary function in healthy cats.
    Dyson DH; Allen DG; Ingwersen W; Pascoe PJ; O'Grady M
    Can J Vet Res; 1987 Apr; 51(2):236-9. PubMed ID: 3111675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of acetaldehyde in guinea pigs.
    Mohan M; Rai UC; Reddy LP; Prasanna CV; Ramakrishnan S
    Indian J Physiol Pharmacol; 1981; 25(3):246-52. PubMed ID: 7298149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental aldose reductase inhibition by Silybin (preliminary communication).
    Santos J; Mira LB; Freire AM; Azevedo M; Manso C
    Acta Med Port; 1984; 5(4-5):115-7. PubMed ID: 6431756
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of amezinium, a novel antihypotensive drug. II. Examination of cardiovascular effects.
    Lehmann HD; Giertz H; Kretzschmar R; Lenke D; von Philipsborn G; Raschack M; Schuster J
    Arzneimittelforschung; 1981; 31(9a):1544-57. PubMed ID: 7197969
    [No Abstract]   [Full Text] [Related]  

  • 30. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological profile of 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go-10213), a new antiprotozoal agent, in comparison with metronidazole.
    David J; Grewal RS; Kaul CL; Nargunde HS; Wagle GP; Ringe SY; Acharya TK
    Arzneimittelforschung; 1985; 35(4):721-6. PubMed ID: 4015738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cardiovascular effects of protamine in rats and isolated rat heart.
    Kertesz R; Walker MJ
    Proc West Pharmacol Soc; 1993; 36():53-7. PubMed ID: 8378398
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibition of pentobarbital metabolism by silymarin. I. Pharmacokinetics].
    Cárceles A; Fratti M; Arboix M; Laporte JR
    Arch Farmacol Toxicol; 1978 Apr; 4(1):123-7. PubMed ID: 697377
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
    Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
    Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of a polyflavane on acute experimental hypertension in the dog].
    Baïsset A; Foulhoux P; Montastruc P
    Therapie; 1976; 31(5):659-65. PubMed ID: 1013958
    [No Abstract]   [Full Text] [Related]  

  • 36. Silybin inhibition of human T-lymphocyte activation.
    Meroni PL; Barcellini W; Borghi MO; Vismara A; Ferraro G; Ciani D; Zanussi C
    Int J Tissue React; 1988; 10(3):177-81. PubMed ID: 3265704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacologic properties of silybin and silymarin].
    Lecomte J
    Rev Med Liege; 1975 Feb; 30(4):110-4. PubMed ID: 1224091
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of angiotensin converting enzyme inhibitor on cardiovascular response to lower body negative pressure [proceedings].
    Adigun SA; Clough D; Conway J; Hatton R
    J Physiol; 1980 Jan; 298():30P-31P. PubMed ID: 6153719
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inhibition of the enzyme-catalyzed degradation of indole-3-acetic acid by silybin, dilydianin, and Silychristin (author's transl)].
    Greimel A; Koch H
    Planta Med; 1977 Dec; 32(4):331-41. PubMed ID: 594207
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemodynamic effects of infused norepinephrine in dogs on cardiopulmonary bypass.
    Kirkendol PL; Woodbury RA
    J Pharmacol Exp Ther; 1972 May; 181(2):369-76. PubMed ID: 5030677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.